21st International Congress » Restless Legs Syndrome and Other Sleep Disorders

Date: Tuesday, June 6, 2017

Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:45pm-3:15pm: Abnormal activity in reward system in Parkinson’s disease patients with rapid eye movement sleep behavior disorder

C. BEAL, M.L. FANTINI, G. SESCOUSSE, M. ULLA, C. CHASSAIN, A. Marques, B. Pereira, N. VITELLO, P. BEUDIN, R. Colamarino, F. DURIF (Clermont-Ferrand, France)

1:45pm-3:15pm: Impaired cerebral and systemic endothelial dysfunction in patients with restless legs syndrome

M.S. Kim, J.H. Yoon (Suwon, Republic of Korea)

1:45pm-3:15pm: Manifestations of restless legs syndrome and its influence on the clinical course of associated migraine

M. Sanoeva (Bukhara, Uzbekistan)

1:45pm-3:15pm: Perceptual decision making and reflection impulsivity in drug naïve and treated patients with restless legs syndrome

B. Heim, M.-T. Pertl, A. Stefani, A. Heidbreder, L. Zamarian, E. Brandauer, B. Averbeck, M. Delazer, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

1:45pm-3:15pm: Prevalence of Restless Legs Syndrome in hemodialyzed patients

I. Estrada-Bellmann, S. Castillo-Torres, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías (Monterrey, Mexico)

1:45pm-3:15pm: Psycho-behavioral profile of Parkinson’s disease patients with RLS: a cross sectional-study

A. MARQUES, M. Figorilli, B. Pereira, P. Derost, B. Debilly, P. Beudin, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

1:45pm-3:15pm: Restless Legs Syndrome in Functional Movement Disorders

T. Serranova, M. Slovak, D. Kemlink, K. Sonka, E. Ruzicka (Prague, Czech Republic)

1:45pm-3:15pm: Restless Legs Syndrome in hemodialyzed patients: a case-control study.

I. Estrada-Bellmann, S. Castillo-Torres, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías (Monterrey, Mexico)

1:45pm-3:15pm: Restless legs syndrome in pregnancy: frequency and impact on quality of life and sleep

S. Telarovic, L. Condic, I. Telarovic (Zagreb, Croatia)

1:45pm-3:15pm: The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Medicines for the Treatment of Restless Legs Syndrome (RLS): A Review of the Labels of Medicines Approved by the FDA and the EMA

M.-P. Emery, C. Anfray, L.-L. Perrier, C. Acquadro (Lyon, France)

« View all sessions from the 21st International Congress.